Tag : Medical

CCT Impact

Trulieve Brings Medical Cannabis to Osprey

CCT IMPACT Agent
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States, announced today the opening of a brand-new Florida dispensary, the Company’s 87th nationwide. The dispensary supports Trulieve’s goal of ensuring direct, reliable access to registered medical cannabis patients across Florida and joins nearby locations in Sarasota, Englewood,......
CCT Impact

Parallel’s goodblend™ Texas Launches First Medical Cannabis Capsule Format for Patients in the Texas Compassionate Use Program

CCT IMPACT Agent
goodblend™ Texas, a retail brand of Parallel, one of the nation’s largest privately-held multi-state cannabis operators, today announced the launch of the first cannabis capsules for patients registered in the Texas Compassionate Use Program. These capsules are the fifth medical cannabis format option offered through the company’s Surterra Wellness branded product line, and the......
CCT Impact

Medical Marijuana Market in the U.S. to Cross USD 14.8 Bn by 2027: Global Market Insights Inc.

CCT IMPACT Agent
According to the latest report “U.S. Medical Marijuana Market by Application (Pain Management, Muscle Spasms, Nausea, Anorexia, Seizures), Route of Administration (Inhalation, Oral, Topical), Distribution Channel (Dispensaries, Online), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2027”, by Global Market Insights Inc., the market valuation of medical marijuana in the United States will......
CCT Impact

Khiron Receives Accreditation for UK Medical Cannabis Education and Partners with UK’s Cellen Therapeutics to Improve Clinician Education

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce it has received UK Continuing Professional Development (“CPD”) accreditation for Khiron Academy, the Company’s global medical cannabis education platform. Additionally, following its accreditation,......
CCT Impact

Verilife Opens New Medical Cannabis Dispensary in Williamsport, Pennsylvania

CCT IMPACT Agent
PharmaCann, one of the nation’s largest, privately held cannabis companies, announced today the opening of its newest Verilife medical cannabis dispensary on the Golden Strip in Williamsport, Pennsylvania. Williamsport is the fourth Verilife dispensary in Pennsylvania, with other locations in Chester, Philadelphia (Manayunk) and Shamokin. “As we expand our presence in Pennsylvania,......
CCT Impact

Vireo Health Announces Closing of Previously Announced Divestiture of Ohio Medical Solutions

CCT IMPACT Agent
Vireo Health International, Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), the science-focused, multi-state cannabis company, today announced that the sale of its former subsidiary, Ohio Medical Solutions, LLC, to Ayr Wellness, Inc. closed on March 31, 2021. In connection with the closing of the transaction, Vireo received cash proceeds of $1.15 million,......
CCT Impact

Global $96.17 Billion Medical Marijuana Market to 2026

CCT IMPACT Agent
The “Medical Marijuana Market, By Compound (THC-dominant, CBD-dominant, Balanced THC & CBD), Product Type ( Flower, Concentrates ), Application (Medical, Recreational) and Geography – Global Forecast to 2026” report has been added to ResearchAndMarkets.com’s offering. The Medical Marijuana Market size is projected to reach USD 96.17 Bn by 2027, from USD 13.4 Bn in 2020 growing at a......
CCT Impact

Khiron Medical Cannabis Products Arrive in Germany for Immediate Prescription, Sale and Distribution

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that the Company has successfully delivered EU-GMP medical cannabis product to Germany. In collaboration with Nimbus Health, a leading medical cannabis distributor in Germany, Khiron......
CCT Impact

Parkinson’s Foundation Releases Results of First-Ever Medical Cannabis and Parkinson’s Disease Survey

CCT IMPACT Agent
The Parkinson’s Foundation today announced the results of the medical cannabis and Parkinson’s disease (PD) survey. The survey, titled Weeding Through the Haze: A Survey on Cannabis Use Among People Living with Parkinson’s Disease in the U.S., was distributed to 7,607 people with PD in January 2020, with 1,064 complete responses analyzed. Parkinson’s Foundation Medical......
CCT Impact

Medical Cannabis’ Burgeoning Reputation is a Boon for the Market’s Expansion

CCT IMPACT Agent
The cannabis industry has drastically changed over the course of the last five years. Thanks to shifting consumer sentiments, legislative victories across several major states and the availability of new products for a wide demographic, the cannabis industry has become a major market attracting investors from all over the world.......